The response of tumorigenic human synovial sarcoma (HSS) cell line to 10–5M optimum concentration of retinoic acid (RA) included changes in morphology, growth rate, suppression of anchorage-independent growth, induction of high alkaline phosphatase activity and excessive secretion of a 68 kDA glycoprotein of unknown function. HSS cells pretreated with 10–5M RA exhibited differential response to 3 potent anticancer drugs, namely cisplatin, vincristine and adriamycin. Sensitivity of the cells to cisplatin was found to be considerably enhanced after exposure to retinoic acid.
Get full access to this article
View all access options for this article.
References
1.
AdwankarM.K., ChitnisM.P.: Alteration in natural resistance of sarcoma 180 tumor to buovardin (NSC 259968) following hyperthermia.Tumori, 69: 309–312, 1983.
2.
AdwankarM.K., ChitnisM.P.: Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.Neoplasma, 33: 217–223, 1986.
3.
AzumaM.K., KawamataH., KasaiY., NagamineS., YoshidaH., YanagawaT., SatoM.: Effects of retinoic acid on morphological features and biological markers of neoplastic human salivary intercalated duct cell line culture.Cancer Res., 48: 7219–7223, 1988.
4.
BakkeO., EspevikT.: Retinoic acid induces a specific membrane glycoprotein in human epithelial cell lines.Exp. Cell Res., 180: 20–29, 1989.
5.
BakkeO.: Antagonist effect of glucocorticoid on retinoic acid induces growth inhibition and morphological alterations of human cell line.Cancer Res., 46: 1275–1279, 1986.
6.
ChitnisM.P., AdwankarM.K.: Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.Tumori, 72: 469–473, 1986.
7.
ChitnisM.P., AdwankarM.K.: Enhancement of the in vitro cytotoxicity of bouvardin by verapamil alone and combined with hyperthermia in sarcoma 180 and Ehrlich ascites carcinoma cells.J. Cancer Res. Clin. Oncol., 112: 131–134, 1986.
8.
FairbanksG., SteckT.L., WallachD.F.H.: Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.Biochemistry, 10: 2606–2617, 1971.
9.
GhoshS.N., SeshadriR.: Expression of tumor cell properties in synovial cells in culture.Acta Cytol., 31: 77–80, 1987.
10.
GrewalH.S., MeyskensF.L.Jr., KillenD., ReevesD., KierschT.A., ElletsonH., StrosbergR., KingD., SteinbronnK.: Response of oral leukoplakia to β-carotene.J. Clin. Oncol., 8: 1715–1720, 1990.
11.
HsuT.C., MooreheadA.S.: Mammalian chromosomes in vitro: VII.Heteroploidy in human cell strains. J. Natl. Cancer Inst., 18: 463–471, 1957.
12.
LaemmliU.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature, 227: 680–685, 1970.
13.
LasnitzkiL., BollagW.: Prevention and reversal by retinoid of 3,4 benzpyrene and cigarette smoke condensate, induced hyperplasia and metaplasia of rodent respiratory epithelia.Cancer Treat. Rep., 66: 1375–1380, 1982.
14.
LippmanS.M., KesslerJ.F., MeyskensF.L.: Retinoids as protective and therapeutic anticancer agents.Cancer Treat. Rep., 71: 493–515, 1987.
15.
LotanR.: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells.Biochem. Biophys. Acta, 605: 33–71, 1980.
16.
LotanR., KramerR.H., NeumannG., LotanD., NicolsonG.L.: Retinoic acid induced modifications in the growth and cell surface components of a human carcinoma (HeLa) cell line.Exp. Cell Res., 130: 401–414, 1980.
17.
LowryO.H., RosebroughN.J., FarrA.L., RandallR.J.: Protein measurement with the Folin phenol reagent.J. Biol. Chem., 193: 265–275, 1951.
18.
MeromskyL., LotanR.: Modulation by retinoic acid of cellular, surface exposed and secreted glycoconjugates in cultured human sarcoma cells.J. Natl. Cancer Inst., 72: 203–215, 1984.
19.
MeyskensF.L., GilmartinE., AlbertsD.S., LevinN.S., BrooksR., SalmonS.E., SurwitE.A.: Activity of isotretinoin against squamous cell cancers and preneoplastic lesions.Cancer Treat. Rep., 66: 1315–1319, 1982.
20.
PuckT.T., MarcusP.I.: Action of X-rays on mammalian cells.J. Exp. Med., 103: 653–666, 1956.
21.
ReeseD.H., FiorentinoG.J., ClaflinA.J., MalininT.I., PolitanoV.A.: Rapid induction of alkaline phosphatase activity by retinoic acid.Biochem. Biophys. Res. Commun., 102: 315–321, 1981.
22.
ReeseD.H., GordonB., GratznerH.G., ClaflinA.J., MalininT.I., BlockN.L., PolitanoV.A.: Effect of retinoic acid on growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphataseCancer Res., 43: 5443–5450, 1983.
23.
ReissM., Gamba-VitaloG., SartorelliA.C.: Induction of tumor cell differentiation as a therapeutic approach: Preclinical models for hematopoietic and solid neoplasms.Cancer Treat. Rep., 70: 201–218, 1986.
24.
SaffiottiU., MontesanoR., SellakumarA.R., BorgS.A.: Experimental cancer of the lung and inhibition by vitamin A of the tracheo-bronchial squamous metaplasia and squamous cell tumors.Cancer, 20: 857–864, 1967.
25.
TheinR., LotanR.: Sensitivity of cultured human osteosarcoma and chondrosarcoma cells to retinoic acids.Cancer Res., 42: 4771–4775, 1982.
